A
Arjumand Ather
Researcher at University of Tromsø
Publications - 22
Citations - 1011
Arjumand Ather is an academic researcher from University of Tromsø. The author has contributed to research in topics: Quantitative structure–activity relationship & Tyrosinase. The author has an hindex of 12, co-authored 22 publications receiving 948 citations. Previous affiliations of Arjumand Ather include University of Karachi & University of Ferrara.
Papers
More filters
Book ChapterDOI
Potentials of phenolic molecules of natural origin and their derivatives as anti-HIV agents.
TL;DR: Some findings using in silico approaches, like virtual screening, docking, neural network, etc., and even the chemogenomics and/or functional genomics approaches could be useful for the quick identifying promising new lead anti-HIV molecules without having any other unwanted pharmacological effects.
Journal ArticleDOI
Effects of vanadium complexes on cell growth of human leukemia cells and protein-DNA interactions
Ilaria Lampronti,Nicoletta Bianchi,Monica Borgatti,Enrica Fabbri,Leonardo Vizziello,Mahmud Tareq Hassan Khan,Arjumand Ather,Dan Brezena,Mohammad Mahroof Tahir,Roberto Gambari +9 more
TL;DR: This research investigated the in vitro antiproliferative activity of a variety of vanadium-containing compounds, and study their ability to interfere with the molecular interactions between GATA-1 and NF-kappaB transcription factors and target DNA elements, employing electrophoretic mobility shift assays.
Journal ArticleDOI
Structure-based analysis of the molecular recognitions between HIV-1 TAR-RNA and transcription factor nuclear factor-kappaB (NFkB).
Mahmud Tareq Hassan Khan,Carlo Mischiati,Arjumand Ather,Tatsuya Ohyama,Kenichi Dedachi,Monica Borgatti,Noriyuki Kurita,Roberto Gambari +7 more
TL;DR: The results presented strongly indicate that interactions between transcription factors recruited at the level of HIV-1 LTR might interact with the TAR-RNA and deserve further studies aimed to determine its role in the HIV- 1 life cycle.
Journal ArticleDOI
Atom‐Based 2D Quadratic Indices in Drug Discovery of Novel Tyrosinase Inhibitors: Results of In Silico Studies Supported by Experimental Results
Yovani Marrero Ponce,Yovani Marrero Ponce,Mahmud Tareq Hassan Khan,Mahmud Tareq Hassan Khan,Gerardo M. Casañola Martín,Gerardo M. Casañola Martín,Arjumand Ather,M. N. Sultankhodzhaev,Francisco Torrens,Richard Rotondo,Ysaias Alvarado +10 more
TL;DR: A role for TOMOCOMD-CARDD descriptors in the biosilico discovery of novel tyrosinase inhibitors from large databases of chemical structures (virtual or “in silico”), which may be used to prevent or treat pigmentation disorders is supported.
Proceedings ArticleDOI
Bond-Based 2D Quadratic Fingerprints in QSAR Studies. Virtual and In Vitro Tyrosinase Inhibitory Activity Elucidation
Yovani Marrero-Ponce,Gerardo M. Casañola-Martin,Mahmud Tareq Hassan Khan,Arjumand Ather,Kalid Khan,Vicente Romero Zaldivar,Francisco Torrens,Richard Rotondo,Facundo Pérez-Jiménez +8 more